Renaissance Technologies LLC Acquires Shares of 66,500 Waldencast plc (NASDAQ:WALD)

Renaissance Technologies LLC bought a new position in shares of Waldencast plc (NASDAQ:WALD) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 66,500 shares of the company’s stock, valued at approximately $239,000. Renaissance Technologies LLC owned approximately 0.05% of Waldencast as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also made changes to their positions in the company. Catalina Capital Group LLC purchased a new stake in Waldencast in the first quarter valued at approximately $73,000. Norden Group LLC acquired a new position in shares of Waldencast in the 1st quarter valued at $92,000. Finally, Bleakley Financial Group LLC purchased a new stake in Waldencast in the 1st quarter valued at $142,000. 41.97% of the stock is owned by hedge funds and other institutional investors.

Waldencast Stock Performance

Shares of Waldencast stock opened at $3.32 on Friday. Waldencast plc has a one year low of $2.40 and a one year high of $12.00. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.78 and a current ratio of 1.47. The firm has a fifty day moving average of $3.40 and a two-hundred day moving average of $4.12.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the stock. DA Davidson upped their target price on shares of Waldencast from $6.50 to $7.25 and gave the company a “buy” rating in a report on Wednesday, September 4th. Telsey Advisory Group restated an “outperform” rating and issued a $6.00 price target on shares of Waldencast in a research report on Wednesday.

Waldencast Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.